Biohaven Ltd. (BHVN)
13.14
+1.22
(+10.23%)
USD |
NYSE |
Jan 16, 16:00
13.17
+0.03
(+0.23%)
After-Hours: 20:00
Biohaven Shareholders Equity (Quarterly): -17.16M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| Nektar Therapeutics | 85.09M |
| Stereotaxis, Inc. | 11.53M |
| Xencor, Inc. | 625.32M |
| Soleno Therapeutics, Inc. | 494.80M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 409.12M |
| Total Liabilities (Quarterly) | 426.28M |
| Debt to Equity Ratio | -18.31 |
| Current Ratio | 2.863 |
| Net Debt Paydown Yield | -3.58% |